Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Yaniv Sherer"'
Autor:
Nadav Zacks, Amir Bar-Shai, Hezi Levi, Anna Breslavsky, Shlomo Maayan, Tsyba Evgenia, Shlomo Feitelovich, Ori Wand, Moshe Schaffer, Yaniv Sherer, Gili Givaty, Anat Tzurel Ferber, Tal Michael, Natalya Bilenko
Publikováno v:
Vaccines, Vol 10, Iss 9, p 1443 (2022)
Background: SARS-CoV-2 is a novel human pathogen causing Coronavirus Disease 2019 that has caused widespread global mortality and morbidity. Since health workers in Israel were among the first to be vaccinated, we had a unique opportunity to investig
Externí odkaz:
https://doaj.org/article/9c1ec3b88bda49f89c20167d8124be86
Autor:
Daniel J. Jakobson, Osnat Bashkin, Viktoria Kalatskaya, Halel Veinberg, Evgeny Chernoguz, Vicky Nesi, Chezy Levy, Yaniv Sherer
Background: Delays in admitting patients to the ICU can defer the timely initiation of life-sustaining therapies and invasive monitoring, jeopardizing the success of the treatment. The current study aimed to assess the factors related to delays in ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d955ecdc89f76c79927dd4015b5b5f67
https://doi.org/10.21203/rs.3.rs-1966914/v2
https://doi.org/10.21203/rs.3.rs-1966914/v2
Autor:
Chaim Yosefy, Yaniv Sherer, Jamal Jafari, Nasi Viki, Azriel Osherov, Sharon Bruoha, Jonathan Rieck, Enrique Gallego-Colon, Yan Orlov, Abu Hamed Jihad
Publikováno v:
The American Journal of Emergency Medicine
Background Despite the COVID-19 pandemic, cardiovascular disease is still the main cause of death in developed countries. Of these deaths, acute coronary syndromes (ACS) account for a substantial percentage of deaths. Improvement in ACS outcomes, are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd3cd46214d5166860ab74bc19f0d294
http://europepmc.org/articles/PMC8088905
http://europepmc.org/articles/PMC8088905
Autor:
Nicola Bizzaro, Yaniv Sherer, Lior Sagi, Maya Ram, Sharon Baum, Yehuda Shoenfeld, Marielle Sanmarco, Ori Barzilai
Publikováno v:
Human Antibodies. 23:27-30
Background Pemphigus and bullous pemphigoid are two autoimmune diseases that have similar pathogenesis. Both have a genetic predisposition, which promotes the production of auto antibodies targeted against different components of the epidermal desmos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::828143a213ca1db9271841c451ecd739
https://doi.org/10.3233/hab-140280
https://doi.org/10.3233/hab-140280
Autor:
Eyal Lotan, Avi Shina, Gilad Twig, Orna Komisar, Ariel Furer, Eyal Klang, Einat Slonimsky, Oshry Mozes, Yehuda Shoenfeld, Ibrahim Marai, Dana Ben-Ami Shor, Yaniv Sherer, Mike Welt, Howard Amital, Gal Yaniv
Publikováno v:
Autoimmunity Reviews. 14:75-79
Recent research in systemic lupus erythematosus (SLE) yielded new antigens and antibodies in SLE patients. We describe the various autoantibodies that can be detected in patients with SLE. A literature review, using the terms “autoantibody” and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e8ac3bd5dad3ecee33ad3e6a0e6abe9
https://doi.org/10.1016/j.autrev.2014.10.003
https://doi.org/10.1016/j.autrev.2014.10.003
Antiphospholipid antibodies (aPL) may accompany a response to many infectious agents. The emergence of aPL may be transient or associated with the clinical picture of antiphospholipid syndrome (APS) with thrombosis, recurrent foetal loss, central ner
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b92c44df43392489424acc288b018b20
https://doi.org/10.1016/b978-0-444-63655-3.00011-9
https://doi.org/10.1016/b978-0-444-63655-3.00011-9
Publikováno v:
The Journal of Arthroplasty. 29:1072-1075
The purpose of this study was to determine patients' survival after undergoing an early or delayed operation. We retrospectively assessed 1849 files of patients operated for proximal femoral fracture, divided into two diagnostic groups: intracapsular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d7020d1848906c69cee24589d97ff9d
https://doi.org/10.1016/j.arth.2013.10.021
https://doi.org/10.1016/j.arth.2013.10.021
Autor:
Dana Ben-Ami, Shor, Guy A, Weiss, Ori, Barzilai, Maya, Ram, Juan-Manuel, Anaya, Yehuda, Shoenfeld, Yaniv, Sherer
Publikováno v:
The Israel Medical Association journal : IMAJ. 17(9)
The association between antiphospholipid antibodies (aPL) and multiple sclerosis (MS) has been suggested previously, but prior studies provided contradicting findings.To characterize the expression profile of eight classic and non-classic aPL in pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9b54c353c3fad32155f484341313297e
https://pubmed.ncbi.nlm.nih.gov/26625546
https://pubmed.ncbi.nlm.nih.gov/26625546
Autor:
Sharon Baum, Yehuda Shoenfeld, Nancy Agmon-Levin, Ori Barzilai, Yaniv Sherer, Nicola Bizzaro, Henri Trau, Maya Ram, Lior Sagi, Bat sheva Porat Katz, Marielle Sanmarco
Publikováno v:
Autoimmunity Reviews. 10:527-535
Pemphigus and bullous pemphigoid are two autoimmune diseases that have a similar pathogenesis. Both have a genetic predisposition which promotes the production of auto-antibodies targeted against different components of the epidermal desmosome and he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38316297872ae24dbfb93deb9eb40377
https://doi.org/10.1016/j.autrev.2011.04.003
https://doi.org/10.1016/j.autrev.2011.04.003
Publikováno v:
Autoimmunity. 43:98-102
Systemic lupus erythematosus (SLE) is an autoimmune rheumatic disease that has a late mortality phase owing mainly to cardiovascular manifestations. Atherosclerosis itself is characterized by inflammatory components, fulfilling the criteria of Witebs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::366538b6f674659bf4334c71298f8dd3
https://doi.org/10.3109/08916930903374527
https://doi.org/10.3109/08916930903374527